lobbying_activities: 3341977

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3341977	075918b8-436e-445d-976b-db3c78835d08	Q1	HANCE SCARBOROUGH	17443	ALLIANCE FOR PHARMACY COMPOUNDING	2025	first_quarter	PHA	Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2025-04-17T15:30:19-04:00